The Orphenadrine Citrate Extended-Re, cataloged under National Stock Number 6505-01-214-1647, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Goldline Laboratories, Inc. Dba Goldline Laboratories. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-214-1647 |
| Primary Part Number | NDC00182-0813-05 |
| Item Name | Orphenadrine Citrate Extended-Re |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Goldline Laboratories, Inc. Dba Goldline Laboratories |
| Status | ACTIVE |
| Primary Container Content Quantity | 500.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00182-0813-05 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| Reference | Meaning |
|---|---|
| NORFLEX | 5/1 Secondary reference 3m Company Health Care/mfg |
| NDC00089-221-50 | 5/9 Secondary reference 3m Company Health Care/mfg |
NSN 6505-01-214-1647 is a Orphenadrine Citrate Extended-Re, manufactured by Goldline Laboratories, Inc. Dba Goldline Laboratories, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-214-1647 has 1 manufacturer part number on file: NDC00182-0813-05 (Goldline Laboratories, Inc. Dba Goldline Laboratories).
Key specifications for NDC00182-0813-05: Primary Container Content Quantity: 500.000 TABLETS; Primary Container Type: BOTTLE; Special Features: LONG ACTION METHOD:EXTENDED RELEASE;; Active Medicament Medicinal Strength: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.